<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39385666</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1741-3850</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of public health (Oxford, England)</Title><ISOAbbreviation>J Public Health (Oxf)</ISOAbbreviation></Journal><ArticleTitle>Association between public health measures and the public's well-being during the pandemic: a nationwide Japanese study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">fdae274</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/pubmed/fdae274</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The present study aimed to investigate the association between the duration of anti-coronavirus disease 2019 (COVID-19) public health measures and the quality of life (QOL) and mental health of the Japanese public.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The present, nationwide, questionnaire-based, cross-sectional study was conducted in September 2021. The cumulative duration in days of anti-COVID-19 public health measures was calculated for each prefecture in the year prior to the survey, and multilevel linear regression analysis was used to determine the association between the duration of these measures and any impairment of QOL or mental health as assessed by the EuroQol 5-dimensions 5-levels (EQ-5D-5L) and the Kessler scale (K6).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study included 28 118 participants from all 47 prefectures. The median duration of public health measures of all prefectures was 179 days. Long-term duration of the measures (181-365 days) was not independently associated with low EQ-5D-5L (P = 0.128) or high K6 (P = 0.179) scores after adjusting for potential confounders (Graphical Abstract).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prolongation of the measures may not be associated with a deterioration in the QOL or mental health of the Japanese public. Nevertheless, it may be necessary to reconsider long-term public health measures given the potential they may have to cause collateral damage, such as socioeconomic one.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miwa</LastName><ForeName>Toshiki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Hitoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takamatsu</LastName><ForeName>Akane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate School of Public Health, St. Luke's International University, 10-1 Akashi-cho, Chuo-ku, Tokyo 104-0044, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabuchi</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka 541-8567, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniguchi</LastName><ForeName>Kiyosu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Hospital Organization, Mie Medical Center, 357 Ozatokubota-cho, Tsu, Mie 514-0125, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tokyo Foundation for Policy Research, 3-2-1 Roppongi, Minato-ku, Tokyo 106-6234, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibuya</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Tokyo Foundation for Policy Research, 3-2-1 Roppongi, Minato-ku, Tokyo 106-6234, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokuda</LastName><ForeName>Yasuharu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9325-7934</Identifier><AffiliationInfo><Affiliation>Tokyo Foundation for Policy Research, 3-2-1 Roppongi, Minato-ku, Tokyo 106-6234, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Muribushi Okinawa Center for Teaching Hospitals, 3-42-8-901 Iso, Urasoe, Okinawa 901-2132, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>16KK0059</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country /></Grant><Grant><GrantID>JPMJPF2017</GrantID><Agency>JST</Agency><Country /></Grant><Grant><GrantID>19FA1012</GrantID><Agency>Health Labour Sciences Research</Agency><Country /></Grant><Grant><GrantID>R3-2-2</GrantID><Agency>Innovative Research Program on Suicide Countermeasures</Agency><Country /></Grant><Grant><Agency>Chiba Foundation for Health Promotion &amp; Disease Prevention</Agency><Country /></Grant><Grant><GrantID>SK202116</GrantID><Agency>2021-2022 Strategic Research Promotion</Agency><Country /></Grant><Grant><Agency>Yokohama City University</Agency><Country /></Grant><Grant><Agency>Using Health Metrics to Monitor and Evaluate the Impact of Health Policies</Agency><Country /></Grant><Grant><Agency>Tokyo Foundation for Policy Research</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Public Health (Oxf)</MedlineTA><NlmUniqueID>101188638</NlmUniqueID><ISSNLinking>1741-3842</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">behaviour</Keyword><Keyword MajorTopicYN="N">communicable diseases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39385666</ArticleId><ArticleId IdType="doi">10.1093/pubmed/fdae274</ArticleId><ArticleId IdType="pii">7816692</ArticleId></ArticleIdList></PubmedData></PubmedArticle>